Focus Stocks
Smith & Wesson to Present at Conferences
Published on Thursday, 02 February 2012 16:32 Written by TradersHuddle Staff
SPRINGFIELD, Mass., Feb. 2, 2012 /PRNewswire/ -- Smith & Wesson Holding Corporation (NASDAQ Global Select: SWHC), a leader in the business of safety, security, protection, and sport, today announced that James Debney, President and CEO, and Jeffrey Buchanan, Executive Vice President and Chief Financial Officer, will present at the Cowen and Company 33rd Annual Aerospace/Defense Conference on Wednesday, February 8, 2012 at 2:45 p.m. (Eastern). This event will be held at Intercontinental Hotel The Barclay in New York City, New York. The Conference will be webcast and may include forward-looking statements. The webcast will be made available on the Company's website at www.smith-wesson.com under the Investor Relations section.
Debney and Buchanan will also attend the Deutsche Bank Small and Midcap Conference on Tuesday, February 14, 2012. This event will be held at the Ritz-Carlton Hotel in South Beach, Florida. The conference will not be webcast.
About Smith & Wesson
Smith & Wesson Holding Corporation (NASDAQ Global Select: SWHC) is a U.S.-based leader in firearm manufacturing. The company delivers a broad portfolio of firearms and related training to the military, law enforcement, and sports markets. Smith & Wesson Holding Corporation companies include Smith & Wesson Corp., the globally recognized manufacturer of quality firearms, and Thompson/Center Arms Company, Inc., a premier designer and manufacturer of premium hunting firearms. Smith & Wesson facilities are located in Massachusetts and Maine. For more information on Smith & Wesson and its companies, call (800) 331-0852 or log on to www.smith-wesson.com.
Contacts:
Liz Sharp, VP Investor Relations
Smith & Wesson Holding Corp.
(413) 747-3304
This e-mail address is being protected from spambots. You need JavaScript enabled to view it.
SOURCE Smith & Wesson Holding Corporation
Related Articles
- Smith & Wesson Holding Corporation Announces Stronger Than Anticipated Fourth Quarter Fiscal 2012 Net Sales
- Smith & Wesson® Unveils New M&P Shield™ Pistol
- Smith & Wesson to Present at Roth Capital Conference
- Smith & Wesson Holding Corporation Reports Third Quarter Fiscal 2012 Financial Results
- Smith & Wesson Third Quarter Fiscal 2012 Financial Release and Conference Call Alert
Related Partner Headlines
- Wedbush Expects Market Share Gains for Smith & Wesson - Benzinga
- Smith & Wesson Shoots from the Hip, Takes Down Analyst Estimates - Benzinga
- Smith & Wesson Shares Surge In Pre-Market On Upbeat Sales Forecast - Benzinga
- Smith & Wesson Sees Q4 Sales of $129M vs $119.8M Est; $113-118M Prior Guidance - Benzinga
- UPDATE: Benchmark Initiates Coverage on Smith & Wesson - Benzinga
- Smith & Wesson Holding Stock Falls On Unusually High Volume (SWHC) - TheStreet.com
- Notable Call Options Activity in Smith & Wesson - Benzinga
TradersHuddle Search
| Sponsored By: |
|
Stock Search: |
|
Site Search: Loading
|
Latest Partner Headlines
-
The EPA's Dangerous Game - TheStreet.com -
Sticking with the Preferred Plan - TheStreet.com -
Infoblox Posts Blowout Earnings; Shares Rise - TheStreet.com -
AutoZone Inc (AZO): Today's Featured Retail Loser - TheStreet.com -
Royal Bank Of Canada (RY): Today's Featured Banking Loser - TheStreet.com -
Salesforce.com Inc. (CRM): Today's Featured Computer Software & Services Loser - TheStreet.com -
CNH Global NV (CNH): Today's Featured Industrial Loser - TheStreet.com -
Warner Chilcott PLC (WCRX): Today's Featured Health Care Loser - TheStreet.com
Stock Market
Dow Jones
Company ID [INDEXDJX:.DJI] Last trade:12,529.75 Trade time:4:05PM EDT Value change:▲33.60 (0.27%)S&P 500
Company ID [INDEXSP:.INX] Last trade:1,320.68 Trade time:4:32PM EDT Value change:▲1.82 (0.14%)NASDAQ
Company ID [INDEXNASDAQ:.IXIC] Last trade:2,839.38 Trade time:5:16PM EDT Value change:▼10.74 (-0.38%)In The Wires
-
CME Group Inc. Declares Quarterly Dividend -
Carly Rae Jepsen to perform live at Cedar Point! -
Tekmira Provides Periodic Update to Shareholders Regarding Litigation -
Taro Provides Results for Three Months Ended March 2012 -
Robbins Umeda LLP Announces an Investigation of Ariba, Inc. -
FDA Advisory Committee Finds Data Support Effectiveness of Tafamidis Meglumine, Pfizer’s Novel Investigational Treatment for Transthyretin Familial Amyloid Polyneuropathy (TTR-FAP) -
Basic Energy Services Announces Reauthorized Share Repurchase Program -
Bottomline Technologies Named 2012 Quality Service Provider of the Year









